As Congress Investigates DTC Genomics Market, Firms Vow Cooperation | GenomeWeb

This article has been updated to include comments from Pathway Genomics.

Originally published May 19.

By Turna Ray

Pathway's attempt to market genetic tests at retail stores Walgreens and CVS/Caremark has not only invited regulatory scrutiny from the US Food and Drug Administration, but now it has raised eyebrows at the US Congress.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.